Evaluation of Diabetes Care at Austrian GPs

Type 2 Diabetes Clinical Trial

— DCA09  

Official title:

Diabetes Care Austria 2009

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT00979394
• Other study ID #: NIS-CAT-DUM-2009/1
• Status: Terminated
• Phase: N/A
• First received: September 17, 2009
• Last updated: August 16, 2010
• Start date: October 2009
• Est. completion date: January 2010

Study information

• Verified date: August 2010
• Source: AstraZeneca
• Contact: n/a
• Is FDA regulated: No
• Health authority: Austria: Ethikkommission
• Study type: Observational

Clinical Trial Summary

This registery should show the medical care of patient with Type 2 Diabetes (T2D) at GP-offices. Furthermore data of co morbidities and risk factors should be evaluated. Objectives of this NIS (cross-sectional study) are:

• To evaluate which characteristics or co-morbidities are being existent for patient with T2D at GP level,

• To evaluate representative profile of patient with T2D in Austria,

• To evaluate which medical therapies are used.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 1513
• Est. completion date: January 2010
• Est. primary completion date: January 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Diabetes mellitus type II

Exclusion Criteria:

• Diabetes mellitus type I

• Gestation diabetes

• Induced diabetes

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Diabetes Mellitus
• Type 2 Diabetes

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
AstraZeneca	Bristol-Myers Squibb

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Evaluate characteristics or co morbidities being existent for patient with T2D at GP		Once per patient	No